Healthcare - Biotechnology - NASDAQ - US
$ 1.69
-1.17 %
$ 81.6 M
Market Cap
-1.37
P/E
INCOME STATEMENT
9.16 M
REVENUE
-75.4 M
OPERATING INCOME
-68.2 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Ikena Oncology, Inc.
| Revenue | 9.16 M |
| Cost Of Revenue | 59.7 M |
| Gross Profit | -50.5 M |
| Operating Expenses | 84.6 M |
| Operating Income | -75.4 M |
| Other Expenses | -7.25 M |
| Net Income | -68.2 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 9.2 | 15.6 | 31.0 | 9.2 | 13.8 | 1.0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 59.7 | 2.0 | 47.1 | 44.8 | 24.9 | 39.0 |
| Gross Profit | (50.5) | 13.6 | (16.1) | (35.7) | (11.2) | (38.0) |
| OPERATING INCOME | ||||||
| Operating Expenses | 84.6 | 86.5 | 65.1 | 53.7 | 32.2 | 41.5 |
| Selling, General and Administrative Expenses | 24.9 | 22.2 | 18.0 | 8.9 | 7.3 | 2.9 |
| Research and Development Expenses | 59.7 | 64.3 | 47.1 | 44.8 | 24.9 | 38.6 |
| Operating Income | (75.4) | (70.9) | (34.1) | (44.5) | (18.5) | (40.9) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 2.1 | 0 | 0 | 0 | 0 |
| Total Other Income | 7.1 | 2.1 | 23 K | 0.3 | 1.7 | 29 K |
| Pre-Tax Income | (68.3) | (68.8) | (34.1) | (44.3) | (16.8) | (40.9) |
| NET INCOME | ||||||
| Tax Provision | (0.2) | (2.1) | 0.3 | 93.7 K | 71.1 K | 0 |
| Net Income | (68.2) | (66.6) | (34.1) | (44.3) | (16.8) | (40.9) |
| EPS | 1.63 | 1.84 | 0.95 | 1.23 | 0.47 | 1.14 |